MP doctor booked under National Security Act for alleged black marketing of Remdesivir

The Indore collector had earlier this week warned that those indulging in black marketing of Remdesivir will be booked under the NSA.

Published On 2021-04-23 04:00 GMT   |   Update On 2021-04-23 14:07 GMT

Indore: Three persons including a doctor were booked under the National Security Act (NSA) for alleged black marketing of Remdesivir injections in Madhya Pradesh's Indore district on Wednesday.

The police had arrested Nilesh Chauhan on April 17 for selling the drug, used in the treatment of COVID-19, at inflated price, said Amrita Solanki, in-charge of Rajendra Nagar police station.

Also Read: Nagpur Doctor booked after nurse alleges molestation

The drug is in high demand currently owing to a massive second wave of the pandemic across the country.

Chauhan's arrest was followed by the arrest of Shubham Parmar, a medical representative, and a doctor with a private hospital, on Sunday, the official said.

The district administration on Wednesday invoked the stringent NSA against them, Solanki said.

The Indore collector had earlier this week warned that those indulging in black marketing of Remdesivir will be booked under the NSA.

Advertisement

Indore, the worst-affected district in Madhya Pradesh, has recorded 94,549 coronavirus cases including 1,069 fatalities to date. 

Also Read:MP: Woman doctor, nurse attacked, held hostage at COVID patient's house, family booked

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News